DEXLANSOPRAZOLE

/static/temp/default.svg

Search structure


Trade Names	DEXILANT DEXILANT SOLUTAB DEXLANSOPRAZOLE
Synonyms	(r)-lansoprazole Dexilant Dexilant solutab Dexlansoprazole Kapidex Lansoprazole r-form Lansoprazole, (r)- NSC-758710 T-168390 TAK-390
Status
Molecule Category	UNKNOWN
ATC	A02BC06
UNII	UYE4T5I70X


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	MJIHNNLFOKEZEW-RUZDIDTESA-N
Smiles	Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2ccccc2[nH]1
InChI	InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C16H14F3N3O2S
Molecular Weight	369.37
AlogP	3.52
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	5.0
Polar Surface Area	67.87
Molecular species	NEUTRAL
Aromatic Rings	3.0
Heavy Atoms	25.0

Bioactivity

Mechanism of Action	Action	Reference
Potassium-transporting ATPase inhibitor	INHIBITOR	PubMed PubMed DailyMed


Protein: Potassium-transporting ATPase Description: Potassium-transporting ATPase alpha chain 1 Organism : Homo sapiens P20648 ENSG00000105675











Protein: Potassium-transporting ATPase Description: Potassium-transporting ATPase subunit beta Organism : Homo sapiens P51164 ENSG00000186009

Targets	EC50(nM)	IC50(nM)	Kd(nM)	Ki(nM)	Inhibition(%)
Enzyme Hydrolase	-	25000	-	-	-
Epigenetic regulator Reader Bromodomain	-	5700	-	-	-
Epigenetic regulator Reader Plant homeodomain	-	5700	-	-	-
Epigenetic regulator Writer Protein methyltransferase	-	5700	-	-	-
Other nuclear protein	-	5700	-	-	-

Related Entries

Cross References

Resources	Reference
ChEBI	135931
ChEMBL	CHEMBL1201863
DrugBank	DB05351
DrugCentral	4162
FDA SRS	UYE4T5I70X
Guide to Pharmacology	5487
PharmGKB	PA166110257
PubChem	9578005
SureChEMBL	SCHEMBL44975
ZINC	ZINC000003830986

CONTENTS

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).